HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen.

AbstractBACKGROUND:
Human strongyloidiasis varies from a chronic but limited infection in normal hosts to hyperinfection in patients treated with corticosteroids or with HTLV-1 co-infection. Regulatory T cells dampen immune responses to infections. How human strongyloidiasis is controlled and how HTLV-1 infection affects this control are not clear. We hypothesize that HTLV-1 leads to dissemination of Strongyloides stercoralis infection by augmenting regulatory T cell numbers, which in turn down regulate the immune response to the parasite.
OBJECTIVE:
To measure peripheral blood T regulatory cells and Strongyloides stercoralis larval antigen-specific cytokine responses in strongyloidiasis patients with or without HTLV-1 co-infection.
METHODS:
Peripheral blood mononuclear cells (PBMCs) were isolated from newly diagnosed strongyloidiasis patients with or without HTLV-1 co-infection. Regulatory T cells were characterized by flow cytometry using intracellular staining for CD4, CD25 and FoxP3. PBMCs were also cultured with and without Strongyloides larval antigens. Supernatants were analyzed for IL-5 production.
RESULTS:
Patients with HTLV-1 and Strongyloides co-infection had higher parasite burdens. Eosinophil counts were decreased in the HTLV-1 and Strongyloides co-infected subjects compared to strongyloidiasis-only patients (70.0 vs. 502.5 cells/mm(3), p = 0.09, Mann-Whitney test). The proportion of regulatory T cells was increased in HTLV-1 positive subjects co-infected with strongyloidiasis compared to patients with only strongyloidiasis or asymptomatic HTLV-1 carriers (median = 17.9% vs. 4.3% vs. 5.9 p<0.05, One-way ANOVA). Strongyloides antigen-specific IL-5 responses were reduced in strongyloidiasis/HTLV-1 co-infected patients (5.0 vs. 187.5 pg/ml, p = 0.03, Mann-Whitney test). Reduced IL-5 responses and eosinophil counts were inversely correlated to the number of CD4+CD25+FoxP3+ cells.
CONCLUSIONS:
Regulatory T cell counts are increased in patients with HTLV-1 and Strongyloides stercoralis co-infection and correlate with both low circulating eosinophil counts and reduced antigen-driven IL-5 production. These findings suggest a role for regulatory T cells in susceptibility to Strongyloides hyperinfection.
AuthorsMartin Montes, Cesar Sanchez, Kristien Verdonck, Jordan E Lake, Elsa Gonzalez, Giovanni Lopez, Angelica Terashima, Thomas Nolan, Dorothy E Lewis, Eduardo Gotuzzo, A Clinton White Jr
JournalPLoS neglected tropical diseases (PLoS Negl Trop Dis) Vol. 3 Issue 6 Pg. e456 (Jun 09 2009) ISSN: 1935-2735 [Electronic] United States
PMID19513105 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Helminth
  • CD4 Antigens
  • FOXP3 protein, human
  • Forkhead Transcription Factors
  • IL5 protein, human
  • Interleukin-2 Receptor alpha Subunit
  • Interleukin-5
Topics
  • Adult
  • Aged
  • Animals
  • Antigens, Helminth (immunology)
  • CD4 Antigens (analysis)
  • Cells, Cultured
  • Female
  • Flow Cytometry
  • Forkhead Transcription Factors (analysis)
  • HTLV-I Infections (complications, immunology)
  • Humans
  • Interleukin-2 Receptor alpha Subunit (analysis)
  • Interleukin-5 (immunology)
  • Leukocytes, Mononuclear (immunology)
  • Male
  • Middle Aged
  • Strongyloides stercoralis (immunology)
  • Strongyloidiasis (complications, immunology)
  • T-Lymphocyte Subsets (chemistry, immunology)
  • T-Lymphocytes, Regulatory (immunology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: